Skip to content

H2020HORIZONFP7

Bayer Aktiengesellschaft

Country
DEGermany
Defence projects
0
Projects, all programmes
86
As coordinator
5
EU contribution (CORDIS)
EUR 4,898,800
Active
2012 to 2026

Projects

86 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
MELLODDYMachinE Learning Ledger Orchestration for Drug DiscoverYH20202019ParticipantEUR 0
EBiSC2EBiSC2 – A sustainable European Bank for induced pluripotent Stem CellsH20202019ParticipantEUR 0
CARDIATEAMCARdiomyopathy in type 2 DIAbetes mellitusH20202019ParticipantEUR 0
EU-STANDS4PMA European standardization framework for data integration and data-driven in silico models for personalized medicineH20202019ParticipantEUR 7,889
V.A. CureA multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomaliesH20202019PartnerEUR 0
HELoSHealth.E Lighthouse Support InitiativeH20202019ParticipantEUR 36,888
Trials@HomeTrials@Home: Center of Excellence – Remote Decentralised Clinical TrialsH20202019ParticipantEUR 0
IMMUcanIntegrated IMMUnoprofiling of large adaptive CANcer patients cohortsH20202019ParticipantEUR 0
FAIRplusFAIRplusH20202019ParticipantEUR 0
ESCulabEuropean Screening Centre; Unique Library for Attractive BiologyH20202018ParticipantEUR 0
DeLIVERSuper-resolution optical microscopy of nanosized pore dynamics in endothelial cellsH20202018PartnerEUR 0
QuanTIIQuantitative T cell Immunology and ImmunotherapyH20202018ParticipantEUR 498,433
IMI-PainCareImproving the care of patients suffering from acute or chronic painH20202018ParticipantEUR 0
EFOEUPATIEnsuring the future of EUPATI beyond 2020H20202018ParticipantEUR 0
PIONEERProstate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRopeH20202018ParticipantEUR 0
ReSOLUTEResearch empowerment on solute carriers (ReSOLUTE)H20202018ParticipantEUR 0
PARADIGMPatients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.H20202018ParticipantEUR 0
c4cconect4children (COllaborative Network for European Clinical Trials For Children)H20202018ParticipantEUR 0
iConsensusIntegrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and productionH20202018ParticipantEUR 0
RUSTWATCHRustWatch: A European early-warning system for wheat rust diseasesH20202018ParticipantEUR 31,254

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.